<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Lai CK</submitter><funding>Food and Health Bureau</funding><funding>Health and Medical Research Fund</funding><journal>The Journal of infection</journal><pagination>S0163-4453(22)00513-8</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9428337</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Remdesivir reduced upper respiratory tract SARS-CoV-2 viral RNA concentration in COVID-19 patients who developed pneumonitis.</pubmed_title><pmcid>PMC9428337</pmcid><funding_grant_id>COVID190107</funding_grant_id><funding_grant_id>COVID19F06</funding_grant_id><pubmed_authors>Yeung AC</pubmed_authors><pubmed_authors>Lai CK</pubmed_authors><pubmed_authors>Chen Z</pubmed_authors><pubmed_authors>Ng RW</pubmed_authors><pubmed_authors>Boon SS</pubmed_authors><pubmed_authors>Ling L</pubmed_authors><pubmed_authors>Chong KC</pubmed_authors><pubmed_authors>Chan PK</pubmed_authors><pubmed_authors>Ho WC</pubmed_authors><pubmed_authors>Lui GC</pubmed_authors><pubmed_authors>Wei Y</pubmed_authors><pubmed_authors>Hui DS</pubmed_authors></additional><is_claimable>false</is_claimable><name>Remdesivir reduced upper respiratory tract SARS-CoV-2 viral RNA concentration in COVID-19 patients who developed pneumonitis.</name><description/><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Aug</publication><modification>2025-05-31T22:52:49.787Z</modification><creation>2024-11-10T08:06:13.442Z</creation></dates><accession>S-EPMC9428337</accession><cross_references><pubmed>36057383</pubmed><doi>10.1016/j.jinf.2022.08.031</doi></cross_references></HashMap>